Dot Blot Protocol: Protein Detection, Antibody Screening and Semi-Quantitative Analysis

Dot blotting is a rapid membrane-based immunoassay used to detect, compare or semi-quantify proteins without electrophoretic separation. Samples are applied directly to nitrocellulose or PVDF, immobilised, blocked and probed with an antibody-based detection system. The method is especially useful for screening many samples, checking antibody reactivity against purified antigens or modified peptides, and estimating target abundance relative to a known standard.

Unlike western blotting, dot blot does not provide molecular-weight information. A positive dot therefore shows antibody recognition of material immobilised on the membrane, but does not prove that the signal arises from a protein of the expected size. Where specificity matters, use dot blot alongside western blot, immunoprecipitation, knockout controls or another orthogonal method.

When to use a dot blot

• Rapidly screen several antibodies against the same antigen.
• Compare reactivity against modified and unmodified peptides.
• Estimate target abundance in crude samples against a purified recombinant-protein standard.
• Check antigen presence before investing time in western blotting or ELISA optimisation.
• Compare sample dilution series or relative expression across conditions.

Equipment and reagents

• Nitrocellulose or PVDF membrane.
• TBS or PBS and detergent-containing wash buffer such as TBST.
• Blocking buffer, commonly BSA or non-fat milk depending on antibody compatibility.
• Primary antibody and labelled secondary antibody.
• Chemiluminescent, fluorescent or colorimetric detection reagent.
• Imaging system appropriate for the label used.
• Optional dot-blot manifold and vacuum source.
• Purified target protein or peptide standard where semi-quantification is planned.

Sample and membrane planning

Plan the membrane layout before loading. Include at least one positive control, one negative or blank control and, where the experiment is comparative, a dilution series of a known target. Mark the membrane lightly in pencil so sample identity is retained through washing and imaging.

For nitrocellulose, samples can often be spotted directly. PVDF typically requires brief methanol activation followed by equilibration in water and buffer before loading. Follow the membrane manufacturer's instructions because wetting behaviour and binding capacity differ between materials.

Dot blot protocol

1. Prepare samples and controls. Normalise sample concentration where possible. Prepare a serial dilution of purified target if a response curve or semi-quantitative comparison is required.
2. Prepare the membrane. Cut to the required size and mark the grid in pencil. If using PVDF, activate and equilibrate according to the manufacturer's instructions.
3. Apply the sample. For manual spotting, apply a small volume slowly to the centre of the marked position and allow it to absorb without touching the membrane with the pipette tip. For a manifold, load the validated volume and apply vacuum according to the device protocol.
4. Immobilise/dry. Allow the membrane to dry or proceed according to the membrane/manifold workflow. Keep conditions consistent across all samples.
5. Block. Incubate the membrane in blocking buffer for approximately 30–60 minutes at room temperature with gentle agitation. A practical starting blocker is 3–5% BSA or non-fat dry milk in TBST; phospho-specific antibodies often perform better with BSA because milk contains phosphoproteins that can increase background.
6. Wash if required. Some workflows proceed directly from blocking to primary antibody; others include a brief wash. Apply one method consistently.
7. Add primary antibody. Dilute according to the antibody datasheet or a prior titration. Incubate for about 1 hour at room temperature or overnight at 4°C for lower-abundance targets.
8. Wash thoroughly. Three washes of approximately 5–10 minutes are a practical starting point.
9. Add labelled secondary antibody. Use a species-appropriate HRP-, AP- or fluorophore-conjugated secondary at the validated dilution. Incubate about 30–60 minutes at room temperature.
10. Wash again. Remove unbound secondary thoroughly to minimise background.
11. Detect signal. Apply the substrate or image the fluorescent label according to the detection chemistry.
12. Acquire non-saturated images. If using chemiluminescence, capture multiple exposure times so the strongest dots do not saturate.

Controls

• Positive control: purified recombinant target or a known positive sample.
• Negative control: irrelevant protein, target-negative sample or unmodified peptide where testing modification specificity.
• No-primary control: estimates secondary-antibody background.
• Loading series: serial dilutions help determine whether signal is within a useful dynamic range.

Semi-quantitative analysis

Dot intensity can be quantified by densitometry if acquisition is unsaturated and background is subtracted consistently. For unknown samples, compare within the linear portion of a purified-protein standard curve. Do not assume that signal is proportional to concentration across the full intensity range; membrane binding, epitope accessibility and detector saturation can all distort linearity.

Advantages and limitations

• Advantages: rapid, inexpensive, simple, suitable for many samples and excellent for antibody or antigen screening.
• Limitations: no size information, no separation of isoforms, strong dependence on membrane binding and epitope accessibility, and only semi-quantitative unless carefully validated.

Troubleshooting

References and primary methods

1. Hawkes R, Niday E, Gordon J. A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem. 1982;119:142–147. doi:10.1016/0003-2697(82)90677-7.
2. Smith E, Roberts K, Butcher GW, Galfré G. Monoclonal antibody screening: two methods using antigens immobilized on nitrocellulose. Anal Biochem. 1984;138:119–124. doi:10.1016/0003-2697(84)90778-4.

Choosing nitrocellulose or PVDF

Both nitrocellulose and PVDF can work well for protein dot blots, but they behave differently. Nitrocellulose is convenient, wets easily and generally gives low background. PVDF has high protein-binding capacity and good mechanical strength, which can be useful when the membrane will be stripped and reprobed or handled repeatedly. PVDF normally requires methanol activation before equilibration. Whichever membrane is selected, keep membrane type constant across experiments because absolute signal intensity can change with membrane chemistry.

Dot blot for antibody validation

Dot blot is especially useful during early antibody characterisation because many antigens, peptide modifications and recombinant standards can be placed on one membrane. A useful specificity layout can include target protein, an unrelated protein, modified peptide, matched unmodified peptide and a serial dilution of the positive target. This design helps distinguish concentration-dependent target recognition from general membrane or peptide binding.

For phospho-, acetyl- or methyl-specific antibodies, include the modified peptide and the identical unmodified sequence wherever possible. Specific recognition of the modification should be supported by a strong signal on the modified peptide and weak or absent signal on the unmodified comparator at the same loading amount.

Building a semi-quantitative standard curve

1. Prepare at least four to six concentrations of a purified target spanning the expected sample range.
2. Spot equal volumes using the same membrane and detection conditions as unknowns.
3. Acquire an image with no saturated standards.
4. Measure integrated dot intensity using a consistent circular region of interest.
5. Subtract local or membrane background.
6. Plot corrected intensity against loaded target amount and identify the approximately linear range.
7. Only interpolate unknowns that fall within that validated range; dilute and repeat samples above it.

Quality criteria for a useful dot blot

• Positive control is clearly detected.
• Negative/no-primary control remains near background.
• Serial standards show ordered signal intensity rather than saturation.
• Replicate dots have similar size and intensity.
• Membrane background is even, without edge staining or patchy blocking.
• Unknown samples fall within the useful standard range if semi-quantification is claimed.

Dot blot versus western blot versus ELISA

Choose dot blot when speed, screening and many conditions are the priority. Choose western blot when molecular weight and band specificity matter. Choose ELISA when higher-throughput quantitative measurement in solution is needed. In antibody validation, dot blot is often a useful first screen, but a size-resolved or orthogonal method should follow before strong specificity claims are made.

Frequently asked questions

Can a dot blot prove antibody specificity?

It can support specificity against the immobilised material, especially when appropriate positive and negative antigens are included, but it cannot establish molecular-weight specificity in a biological lysate.

Can I quantify protein concentration by dot blot?

Yes, semi-quantitatively, if a purified standard curve is run on the same membrane and unknowns fall inside a demonstrated linear range. The method is usually less rigorous than a well-validated quantitative ELISA.

Why are my dots spreading?

The loading volume may be too large, the membrane may be overly wet, or the sample may contain detergents/salts that alter spreading. Reduce volume and standardise spotting conditions.

Can I strip and reprobe a dot blot?

Often yes, particularly on PVDF, but stripping can remove some immobilised protein or reduce antigenicity. Validate recovery and avoid comparing absolute intensity before and after stripping without controls.

Explore more with ABMIUM

Need to compare antibodies for dot blot or move from screening into a size-resolved validation? Use Find your MATCH, explore our Western blot protocol, or browse primary antibodies.